Apollo Therapeutics raised $226.5m in Series C funding led by Patient Square Capital, joined by M&G, Rock Springs Capital Biotech Manufacturing Pharma Investments 03 September 2023 Share:
Round value (USD): 226.5m Round investors: M&G Investments Patient Square Capital Rock Springs Capital Company: Apollo Therapeutics Industry: Biotech Manufacturing Pharma
Beacon Therapeutics raised £96M series A with Syncona Health services Manufacturing Pharma Investments 03 June 2023